News and Updates

Now recruiting interested participants for the T-Force Gold Tourette Syndrome Study in ages 6-17

Wednesday, January 24, 2018


We invite boys and girls aged 6 to 17 who have Tourette syndrome to see if they may qualify for the T-Force Gold Study. The primary purpose of this research study is to determine the effectiveness, safety, and tolerability of an investigational medication for Tourette syndrome. Each child who qualifies will receive study medication, study-related medical exams, and study-related laboratory tests at no cost. 

Compensation for time and travel may be available. 

To learn more, and to see if your child may qualify, visit TForceGoldStudy.com or contact our Clinical Research Coordinator!

Brooke Grubb

Clinical Research Coordinator

Neurobehavioral Medicine Group

Clinical Trials Division

Office: 248.290.5400

Fax: 248.290.5401

Brookeg@neurobmg.com